BioCentury | Nov 15, 2010
Strategy

Lilly avid for diagnostics

Eli Lilly and Co. 's acquisition of Avid Radiopharmaceuticals Inc. represents the first significant step in the pharma's efforts to build a diagnostics revenue stream. While Lilly is interested in companion diagnostics, it says this...
BioCentury | Oct 29, 2007
Emerging Company Profile

Avid: Quick and early

There is keen interest in developing early diagnostics for degenerative diseases where early therapeutic intervention is likely to provide the greatest benefit but diagnosis is still largely dependent on an assessment of symptoms. Avid Radiopharmaceuticals...
BC Week In Review | Oct 8, 2007
Clinical News

AV-133: Phase I started

Avid began a U.S. Phase I trial in 30 patients. Avid Radiopharmaceuticals Inc. , Philadelphia, Penn.   Product: AV-133   Business: Diagnostic   Molecular target: NA   Description: 18F-labeled PET imaging agent that targets vesicular monoamine...
Items per page:
1 - 3 of 3